 |
|
Human Papillomavirus and Widespread Cutaneous Carcinoma After PUVA Photochemotherapy
Martin A. Weinstock, MD;
Silvija Coulter, MS;
Jeannie Bates;
Hendrik A. Bogaars, MD;
Pamela L. Larson, MD;
Glenna C. Burmer, MD
Arch Dermatol. 1995;131(6):701-704.
Abstract
Background
Oral psoralen with UV-A (PUVA) photochemotherapy is known to cause cutaneous malignancies and has been associated with cutaneous immunosuppression. Human papillomavirus infection has also been associated with cutaneous malignancies and with immunosuppressed individuals. We therefore sought evidence of human papillomavirus infection in a patient with a long history of PUVA therapy and multiple cutaneous malignancies.
Observations
During a 15-year period, an otherwise healthy patient with psoriasis who had undergone a 10-year course of PUVA photochemotherapy developed 13 squamous cell carcinomas, eight lesions diagnosed as ''squamous cell carcinoma vs keratoacanthoma,'' 14 other keratoacanthomas, six basal cell carcinomas, one melanoma in situ, and 18 other keratinocytic dysplasias. Twenty-two of the 30 lesions tested for human papillomavirus DNA by polymerase chain reaction were positive for type 16/18, including six of the seven basal or squamous cell carcinomas tested.
Conclusion
We hypothesize that PUVA therapy-induced immunosuppression may play an important role in PUVA-related carcinogenesis by affecting the extent and pathogenicity of human papillomavirus infection.
(Arch Dermatol. 1995;131:701-704)
Author Affiliations
From the Dermatoepidemiology Unit, Veterans Affairs and Roger Williams Medical Centers and Brown University, Providence, RI (Drs Weinstock and Larson) and the Departments of Pathology, Roger Williams Medical Center and Brown University (Dr Bogaars) and University of Washington, Seattle (Mss Coulter and Bates and Dr Burmer). Dr Larson is now in private practice in Rochester, NY.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Increased Prevalence of Human Papillomavirus in Hairs Plucked From Patients With Psoriasis Treated With Psoralen-UV-A
Wolf et al.
Arch Dermatol 2004;140:317-324.
ABSTRACT
| FULL TEXT
p53 in Dermatology
Gasparro
Arch Dermatol 1998;134:1029-1032.
FULL TEXT
Demonstration of Human Papillomavirus Type 16-Related DNA and Absence of Detectable p53 Gene Mutations in Widespread Cutaneous Squamous Cell Carcinomas After Oral Psoralen With UV-A Treatment
Rubben et al.
Arch Dermatol 1996;132:1257-1259.
ABSTRACT
Psoralen Plus UV-A-Associated Skin Cancer: A Likely Role for Human Papillomavirus Type 16?
McGregor et al.
Arch Dermatol 1996;132:90-90.
ABSTRACT
|
